Latest Drug Approvals news
FDA Approves Nemluvio for Moderate-to-Severe Atopic Dermatitis
posted December 18th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Kebilidi for Aromatic L-Amino Acid Decarboxylase Deficiency
posted November 27th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Bimzelx for Hidradenitis Suppurativa
posted November 25th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Cobenfy for Adults With Schizophrenia
posted November 14th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Nighttime Light Exposure Linked to Sleep Parameters in Schizophrenia 
Psychiatrists Only Agree 55 Percent of the Time on Diagnoses 
Brain Abnormalities Identified in Children at Risk for Schizophrenia 
Systemic Physical Multimorbidity Higher With Schizophrenia-Spectrum, Bipolar Disorder Related Articles
Most Speakers at FDA Advisory Committee Meetings Support Drug Approval 
Countries Involved in U.S. Clinical Trials Do Not Gain Timely Access to Approved Medicines 
Approved-Label Populations for New Drugs Broader Than Trial Populations Monthly Specialist Briefings
Stay Connected
